Q4 2021 Holdings
Filed 2022-02-11 | 12 holdings | $49.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $41.1M | 5,665,221 | 84.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $7.8M | 466,200 | 15.9% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $12.6K | 527,150 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $12.4K | 2,608,851 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $11.8K | 3,765,588 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $10.8K | 495,280 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $10.0K | 527,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $7.6K | 560,600 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $7.2K | 456,865 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $3.2K | 1,000,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.8K | 19,200 | 0.0% |
| Neximmune Inc | COM | 65344D109 | $615 | 133,442 | 0.0% |